{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:10:26Z","timestamp":1790683826652,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-024-00963-2","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T08:18:37Z","timestamp":1736151517000},"page":"573-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful treatment with bortezomib for refractory cryoglobulinemic vasculitis triggered by ischemic non-obstructive coronary artery disease"],"prefix":"10.1007","volume":"14","author":[{"given":"Yui","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moriaki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoruko","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Rokutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wako","family":"Yumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomio","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyo","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6283-8146","authenticated-orcid":false,"given":"Takashi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"963_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379:348\u201360.","journal-title":"Lancet"},{"key":"963_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1258\/acb.2009.009180","volume":"47","author":"R Sargur","year":"2010","unstructured":"Sargur R, White P, Egner W. Cryoglobulin evaluation: best practice? Ann Clin Biochem. 2010;47:8\u201316.","journal-title":"Ann Clin Biochem"},{"key":"963_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. a report of 86 cases. Am J Med. 1974;57:775\u201388.","journal-title":"Am J Med."},{"key":"963_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","volume":"128","author":"P Cacoub","year":"2015","unstructured":"Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D. Cryoglobulinemia vasculitis. Am J Med. 2015;128:950\u20135.","journal-title":"Am J Med"},{"key":"963_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autrev.2011.07.005","volume":"11","author":"C Ferri","year":"2011","unstructured":"Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev. 2011;11:48\u201355.","journal-title":"Autoimmun Rev"},{"key":"963_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.transci.2010.03.001","volume":"42","author":"MA Rockx","year":"2010","unstructured":"Rockx MA, Clark WF. Plasma exchange for treating cryoglobulinemia:a descriptive analysis. Transfus Apher Sci. 2010;42:247\u201351.","journal-title":"Transfus Apher Sci"},{"key":"963_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/1744-9987.13885","volume":"27","author":"H Naciri Bennani","year":"2023","unstructured":"Naciri Bennani H, Banza AT, Terrec F, Noble J, Jouve T, Motte L, Malvezzi P, Rostaing L. Cryoglobulinemia and double-filtration plasmapheresis: personal experience and literature review. Ther Apher Dial. 2023;27:159\u201369.","journal-title":"Ther Apher Dial"},{"key":"963_CR8","first-page":"79","volume":"61","author":"M Imoto","year":"2017","unstructured":"Imoto M, Yamada T, Nakae K, Kamisako T. Analysis of cryoglobulin for providing valuable reports from clinical laboratory. Denkieido. 2017;61:79\u201383 ((Japanese)).","journal-title":"Denkieido"},{"key":"963_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytz041","author":"YX Gue","year":"2019","unstructured":"Gue YX, Prasad S, Isenberg D, Gorog DA. A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome. Eur Heart J Case Rep. 2019. https:\/\/doi.org\/10.1093\/ehjcr\/ytz041.","journal-title":"Eur Heart J Case Rep"},{"key":"963_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s10517-011-1155-9","volume":"150","author":"NA Konstantinova","year":"2011","unstructured":"Konstantinova NA, Yeremin II, Konstantinova EV, Karandashov EN, Shostak NA. Cryoglobulin composition in patients with myocardial infarction. Bull Exp Biol Med. 2011;150:412\u20135.","journal-title":"Bull Exp Biol Med"},{"key":"963_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/art.34322","volume":"64","author":"MC Sneller","year":"2012","unstructured":"Sneller MC, Hu Z, Langford CA. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64:835\u201342.","journal-title":"Arthritis Rheum"},{"key":"963_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/art.34331","volume":"64","author":"S De Vita","year":"2012","unstructured":"De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64:843\u201353.","journal-title":"Arthritis Rheum"},{"key":"963_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s12185-013-1323-y","volume":"97","author":"E Besada","year":"2013","unstructured":"Besada E, Vik A, Koldingsnes W, Nossent JC. Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review. Int J Hematol. 2013;97:800\u20133.","journal-title":"Int J Hematol"},{"key":"963_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/1744-9987.12556","volume":"21","author":"Y Taniyama","year":"2017","unstructured":"Taniyama Y, Nakatani Y, Matsuoka T, Takahashi M, Shimizu K, Yamamoto S, Inoue Y, Ohnishi S, Kobayashi N, Nakano Y, Takami M, Arima S. Efficacy of cryofiltration for treatment of mixed cryoglobulinemia: a report of four cases. Ther Apher Dial. 2017;21:238\u201342.","journal-title":"Ther Apher Dial"},{"key":"963_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13730-019-00394-4","volume":"8","author":"Y Kurokawa","year":"2019","unstructured":"Kurokawa Y, Koike K, Kaida Y, Ito S, Chiba H, Urae K, Moriyama T, Nakamura N, Imai T, Shibata R, Hazama T, Wakasugi D, Okuda S, Fukami K. Effectiveness of cryofiltration and mizoribine combination with oral steroid therapy in a patient with membranoproliferative glomerulonephritis due to essential cryoglobulinemia. CEN Case Rep. 2019;8:205\u201311.","journal-title":"CEN Case Rep"},{"issue":"343","key":"963_CR16","first-page":"e1","volume":"3","author":"XX Cao","year":"2018","unstructured":"Cao XX, Tian Z, Lin L, Sun J, Su W, Zhou DB, Li J. Successful treatment of type 1 cryoglobulinemic vasculitis with cardiac involvement. Can J Cardiol. 2018;3(343):e1-343.e3.","journal-title":"Can J Cardiol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00963-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T02:53:37Z","timestamp":1757127217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00963-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00963-2","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The use of plasmapheresis, DFPP, rituximab, and bortezomib for the treatment of cryoglobulinemic vasculitis involved unapproved investigational drugs and was conducted with the approval of our institutional ethics committee. Written informed consent was obtained from the patient for the treatment and for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}